Hasil Pencarian - Alexandra Pender
- Menampilkan 1 - 6 hasil dari 6
-
1
The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer oleh Alexandra Pender, Sanjay Popat
Diterbitkan 2015-06-01
Artikel -
2
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy oleh Rebekah Rittberg, Bonnie Leung, Aria Shokoohi, Alexandra Pender, Selina Wong, Zamzam Al-Hashami, Ying Wang, Cheryl Ho
Diterbitkan 2023-05-01
Artikel -
3
Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing oleh Lauren Jones, Rebekah Rittberg, Bonnie Leung, Aria Shokoohi, Alexandra Pender, Selina Wong, Zamzam Al-Hashami, Ying Wang, Cheryl Ho
Diterbitkan 2022-11-01
Artikel -
4
-
5
Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: younger versus older adults oleh Bonnie Leung, Aria Shokoohi, Zamzam Al-Hashami, Sara Moore, Alexandra Pender, Selina K. Wong, Ying Wang, Jonn Wu, Cheryl Ho
Diterbitkan 2023-04-01
Artikel -
6
Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach. oleh Alexandra Pender, Isaac Garcia-Murillas, Sareena Rana, Rosalind J Cutts, Gavin Kelly, Kerry Fenwick, Iwanka Kozarewa, David Gonzalez de Castro, Jaishree Bhosle, Mary O'Brien, Nicholas C Turner, Sanjay Popat, Julian Downward
Diterbitkan 2015-01-01
Artikel